Redx Pharma Plc (LON:REDX) Insider Lisa Anson Buys 115,000 Shares

Redx Pharma Plc (LON:REDX - Get Free Report) insider Lisa Anson purchased 115,000 shares of the firm's stock in a transaction on Tuesday, April 16th. The shares were acquired at an average price of GBX 9 ($0.11) per share, with a total value of £10,350 ($12,884.35).

Lisa Anson also recently made the following trade(s):

  • On Thursday, April 11th, Lisa Anson purchased 399,000 shares of Redx Pharma stock. The shares were acquired at an average price of GBX 8 ($0.10) per share, with a total value of £31,920 ($39,736.09).

Redx Pharma Stock Performance

Shares of REDX stock opened at GBX 12.75 ($0.16) on Friday. The firm has a market capitalization of £49.60 million, a PE ratio of -127.50 and a beta of -0.53. The firm has a fifty day simple moving average of GBX 16.75 and a two-hundred day simple moving average of GBX 21.11. The company has a current ratio of 1.11, a quick ratio of 1.93 and a debt-to-equity ratio of 527.00. Redx Pharma Plc has a 12 month low of GBX 4 ($0.05) and a 12 month high of GBX 37.90 ($0.47).

About Redx Pharma

(Get Free Report)

Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating fibrotic disease, cancer, and the emerging area of cancer-associated fibrosis in the areas of unmet medical needs. The company also develops zelasudil (RXC007), a selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor, which is in Phase 2 clinical trial for the treatment of multiple interstitial lung diseases and cancer-associated fibrosis; RXC008, a potential first-in-class GI-targeted ROCK inhibitor that is in preclinical studies for the treatment of fibrostenotic Crohn's disease; and zamaporvint (RXC004), a porcupine inhibitor that is in Phase 2 clinical trial for targeted therapy of Wnt-ligand dependent cancers.

Featured Stories


Gold Mania
Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).
See his free reveal right here.


This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Redx Pharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Redx Pharma and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles